Remdesivir for the treatment of COVID-19: A living systematic review

F Verdugo-Paiva, P Acuña, I Sola, G Rada, COVID-19 L·OVE Working Group
doi: https://doi.org/10.1101/2020.09.27.20202754

Article Information

doi 
https://doi.org/10.1101/2020.09.27.20202754
History 
  • September 28, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. F Verdugo-Paiva1,2,
  2. P Acuña3,4,
  3. I Sola5,6,7,
  4. G Rada1,2,
  5. COVID-19 L·OVE Working Group
  1. 1Epistemonikos Foundation, Santiago, Chile
  2. 2UC Evidence Center, Cochrane Chile Associated Center, Pontificia Universidad Católica de Chile, Santiago, Chile
  3. 3Unidad de Infectología, Hospital Dr Sótero del Río, Santiago, Chile
  4. 4Unidad de Infectología, Hospital Clínico Dra Eloísa Díaz, La Florida, Santiago, Chile
  5. 5Biomedical Research Institute Sant Pau, Barcelona, Spain
  6. 6Iberoamerican Cochrane Centre, Barcelona, Spain
  7. 7CIBER Epidemiología y Salud Pública (CIBERESP)
  1. * Corresponding author; email: fverdugo{at}epistemonikos.org
Back to top
Posted September 28, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Remdesivir for the treatment of COVID-19: A living systematic review
F Verdugo-Paiva, P Acuña, I Sola, G Rada, COVID-19 L·OVE Working Group
medRxiv 2020.09.27.20202754; doi: https://doi.org/10.1101/2020.09.27.20202754
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area